-
1
-
-
84898619194
-
-
ACS. Cancer facts & figures
-
ACS. (2013). Cancer facts & figures.
-
(2013)
-
-
-
2
-
-
0035939903
-
Delineation of prognostic biomarkers in prostate cancer
-
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001; 412(6849):822-826.
-
(2001)
Nature
, vol.412
, Issue.6849
, pp. 822-826
-
-
Dhanasekaran, S.M.1
Barrette, T.R.2
Ghosh, D.3
Shah, R.4
Varambally, S.5
Kurachi, K.6
Pienta, K.J.7
Rubin, M.A.8
Chinnaiyan, A.M.9
-
3
-
-
0035423118
-
Expression profiling reveals hepsin overexpression in prostate cancer
-
Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA and Milbrandt J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 2001; 61(15):5692-5696.
-
(2001)
Cancer Res
, vol.61
, Issue.15
, pp. 5692-5696
-
-
Magee, J.A.1
Araki, T.2
Patil, S.3
Ehrig, T.4
True, L.5
Humphrey, P.A.6
Catalona, W.J.7
Watson, M.A.8
Milbrandt, J.9
-
4
-
-
0035174607
-
Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia
-
Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M, Mc Neal JE, Nolley R and Zhang Z. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. The Journal of urology. 2001; 166(6):2171-2177.
-
(2001)
The Journal of urology
, vol.166
, Issue.6
, pp. 2171-2177
-
-
Stamey, T.A.1
Warrington, J.A.2
Caldwell, M.C.3
Chen, Z.4
Fan, Z.5
Mahadevappa, M.6
Mc Neal, J.E.7
Nolley, R.8
Zhang, Z.9
-
5
-
-
0037376293
-
Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer
-
Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA and Stamey TA. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. The Journal of urology. 2003; 169(4):1316-1319.
-
(2003)
The Journal of urology
, vol.169
, Issue.4
, pp. 1316-1319
-
-
Chen, Z.1
Fan, Z.2
McNeal, J.E.3
Nolley, R.4
Caldwell, M.C.5
Mahadevappa, M.6
Zhang, Z.7
Warrington, J.A.8
Stamey, T.A.9
-
6
-
-
10744220367
-
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer
-
Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA and Diamandis EP. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. The Journal of urology. 2004; 171(1):187-191.
-
(2004)
The Journal of urology
, vol.171
, Issue.1
, pp. 187-191
-
-
Stephan, C.1
Yousef, G.M.2
Scorilas, A.3
Jung, K.4
Jung, M.5
Kristiansen, G.6
Hauptmann, S.7
Kishi, T.8
Nakamura, T.9
Loening, S.A.10
Diamandis, E.P.11
-
7
-
-
0035846933
-
Type II transmembrane serine proteases.Insights into an emerging class of cell surface proteolytic enzymes
-
Hooper JD, Clements JA, Quigley JP and Antalis TM. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem. 2001; 276(2):857-860.
-
(2001)
J Biol Chem
, vol.276
, Issue.2
, pp. 857-860
-
-
Hooper, J.D.1
Clements, J.A.2
Quigley, J.P.3
Antalis, T.M.4
-
9
-
-
33750156940
-
Pro-urokinase-type plasminogen activator is a substrate for hepsin
-
Moran P, Li W, Fan B, Vij R, Eigenbrot C and Kirchhofer D. Pro-urokinase-type plasminogen activator is a substrate for hepsin. J Biol Chem. 2006; 281(41):30439-30446.
-
(2006)
J Biol Chem
, vol.281
, Issue.41
, pp. 30439-30446
-
-
Moran, P.1
Li, W.2
Fan, B.3
Vij, R.4
Eigenbrot, C.5
Kirchhofer, D.6
-
10
-
-
15544386767
-
Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2
-
Kirchhofer D, Peek M, Lipari MT, Billeci K, Fan B and Moran P. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS letters. 2005; 579(9):1945-1950.
-
(2005)
FEBS letters
, vol.579
, Issue.9
, pp. 1945-1950
-
-
Kirchhofer, D.1
Peek, M.2
Lipari, M.T.3
Billeci, K.4
Fan, B.5
Moran, P.6
-
11
-
-
21244448682
-
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
-
Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N, Meininger D, Hoey T and Austin RJ. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. The Biochemical journal. 2005; 390(Pt 1):125-136.
-
(2005)
The Biochemical journal
, vol.390
, Issue.PART 1
, pp. 125-136
-
-
Herter, S.1
Piper, D.E.2
Aaron, W.3
Gabriele, T.4
Cutler, G.5
Cao, P.6
Bhatt, A.S.7
Choe, Y.8
Craik, C.S.9
Walker, N.10
Meininger, D.11
Hoey, T.12
Austin, R.J.13
-
12
-
-
5144225237
-
Hepsin promotes prostate cancer progression and metastasis
-
Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ and Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell. 2004; 6(2):185-195.
-
(2004)
Cancer Cell
, vol.6
, Issue.2
, pp. 185-195
-
-
Klezovitch, O.1
Chevillet, J.2
Mirosevich, J.3
Roberts, R.L.4
Matusik, R.J.5
Vasioukhin, V.6
-
13
-
-
33645748575
-
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture
-
Xuan JA, Schneider D, Toy P, Lin R, Newton A, Zhu Y, Finster S, Vogel D, Mintzer B, Dinter H, Light D, Parry R, Polokoff M, Whitlow M, Wu Q and Parry G. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res. 2006; 66(7):3611-3619.
-
(2006)
Cancer Res
, vol.66
, Issue.7
, pp. 3611-3619
-
-
Xuan, J.A.1
Schneider, D.2
Toy, P.3
Lin, R.4
Newton, A.5
Zhu, Y.6
Finster, S.7
Vogel, D.8
Mintzer, B.9
Dinter, H.10
Light, D.11
Parry, R.12
Polokoff, M.13
Whitlow, M.14
Wu, Q.15
Parry, G.16
-
14
-
-
33747016828
-
Variants in the HEPSIN gene are associated with prostate cancer in men of European origin
-
Pal P, Xi H, Kaushal R, Sun G, Jin CH, Jin L, Suarez BK, Catalona WJ and Deka R. Variants in the HEPSIN gene are associated with prostate cancer in men of European origin. Human genetics. 2006; 120(2):187-192.
-
(2006)
Human genetics
, vol.120
, Issue.2
, pp. 187-192
-
-
Pal, P.1
Xi, H.2
Kaushal, R.3
Sun, G.4
Jin, C.H.5
Jin, L.6
Suarez, B.K.7
Catalona, W.J.8
Deka, R.9
-
15
-
-
51649102862
-
Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model
-
Miao J, Mu D, Ergel B, Singavarapu R, Duan Z, Powers S, Oliva E and Orsulic S. Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model. International journal of cancer. 2008; 123(9):2041-2047.
-
(2008)
International journal of cancer
, vol.123
, Issue.9
, pp. 2041-2047
-
-
Miao, J.1
Mu, D.2
Ergel, B.3
Singavarapu, R.4
Duan, Z.5
Powers, S.6
Oliva, E.7
Orsulic, S.8
-
16
-
-
0036894486
-
HEPSIN inhibits cell growth/invasion in prostate cancer cells
-
Srikantan V, Valladares M, Rhim JS, Moul JW and Srivastava S. HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res. 2002; 62(23):6812-6816.
-
(2002)
Cancer Res
, vol.62
, Issue.23
, pp. 6812-6816
-
-
Srikantan, V.1
Valladares, M.2
Rhim, J.S.3
Moul, J.W.4
Srivastava, S.5
-
17
-
-
79960048973
-
Matrix-dependent regulation of AKT in Hepsinoverexpressing PC3 prostate cancer cells
-
Wittig-Blaich SM, Kacprzyk LA, Eismann T, Bewerunge-Hudler M, Kruse P, Winkler E, Strauss WS, Hibst R, Steiner R, Schrader M, Mertens D, Sultmann H and Wittig R. Matrix-dependent regulation of AKT in Hepsinoverexpressing PC3 prostate cancer cells. Neoplasia. 2011; 13(7):579-589.
-
(2011)
Neoplasia
, vol.13
, Issue.7
, pp. 579-589
-
-
Wittig-Blaich, S.M.1
Kacprzyk, L.A.2
Eismann, T.3
Bewerunge-Hudler, M.4
Kruse, P.5
Winkler, E.6
Strauss, W.S.7
Hibst, R.8
Steiner, R.9
Schrader, M.10
Mertens, D.11
Sultmann, H.12
Wittig, R.13
-
18
-
-
70350523855
-
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis
-
Li W, Wang BE, Moran P, Lipari T, Ganesan R, Corpuz R, Ludlam MJ, Gogineni A, Koeppen H, Bunting S, Gao WQ and Kirchhofer D. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Cancer research. 2009; 69(21):8395-8402.
-
(2009)
Cancer research
, vol.69
, Issue.21
, pp. 8395-8402
-
-
Li, W.1
Wang, B.E.2
Moran, P.3
Lipari, T.4
Ganesan, R.5
Corpuz, R.6
Ludlam, M.J.7
Gogineni, A.8
Koeppen, H.9
Bunting, S.10
Gao, W.Q.11
Kirchhofer, D.12
-
19
-
-
34547655938
-
Hepsin and prostate cancer
-
Wu Q and Parry G. Hepsin and prostate cancer. Front Biosci. 2007; 12:5052-5059.
-
(2007)
Front Biosci
, vol.12
, pp. 5052-5059
-
-
Wu, Q.1
Parry, G.2
-
20
-
-
55749113520
-
Identification and characterization of smallmolecule inhibitors of hepsin
-
Chevillet JR, Park GJ, Bedalov A, Simon JA and Vasioukhin VI. Identification and characterization of smallmolecule inhibitors of hepsin. Mol Cancer Ther. 2008; 7(10):3343-3351.
-
(2008)
Mol Cancer Ther
, vol.7
, Issue.10
, pp. 3343-3351
-
-
Chevillet, J.R.1
Park, G.J.2
Bedalov, A.3
Simon, J.A.4
Vasioukhin, V.I.5
-
21
-
-
34247143776
-
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family
-
Kyrieleis OJ, Huber R, Ong E, Oehler R, Hunter M, Madison EL and Jacob U. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family. The FEBS journal. 2007; 274(8):2148-2160.
-
(2007)
The FEBS journal
, vol.274
, Issue.8
, pp. 2148-2160
-
-
Kyrieleis, O.J.1
Huber, R.2
Ong, E.3
Oehler, R.4
Hunter, M.5
Madison, E.L.6
Jacob, U.7
-
23
-
-
12444316010
-
The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain
-
Somoza JR, Ho JD, Luong C, Ghate M, Sprengeler PA, Mortara K, Shrader WD, Sperandio D, Chan H, McGrath ME and Katz BA. The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. Structure. 2003; 11(9):1123-1131.
-
(2003)
Structure
, vol.11
, Issue.9
, pp. 1123-1131
-
-
Somoza, J.R.1
Ho, J.D.2
Luong, C.3
Ghate, M.4
Sprengeler, P.A.5
Mortara, K.6
Shrader, W.D.7
Sperandio, D.8
Chan, H.9
McGrath, M.E.10
Katz, B.A.11
-
24
-
-
0031883020
-
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer
-
Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML and Matusik RJ. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest. 1998; 78(3):319-333.
-
(1998)
Lab Invest
, vol.78
, Issue.3
, pp. 319-333
-
-
Kasper, S.1
Sheppard, P.C.2
Yan, Y.3
Pettigrew, N.4
Borowsky, A.D.5
Prins, G.S.6
Dodd, J.G.7
Duckworth, M.L.8
Matusik, R.J.9
-
25
-
-
84862776643
-
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases
-
Ding Z, Wu CJ, Jaskelioff M, Ivanova E, Kost-Alimova M, Protopopov A, Chu GC, Wang G, Lu X, Labrot ES, Hu J, Wang W, Xiao Y, Zhang H, Zhang J, Zhang J, et al. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell. 2012; 148(5):896-907.
-
(2012)
Cell
, vol.148
, Issue.5
, pp. 896-907
-
-
Ding, Z.1
Wu, C.J.2
Jaskelioff, M.3
Ivanova, E.4
Kost-Alimova, M.5
Protopopov, A.6
Chu, G.C.7
Wang, G.8
Lu, X.9
Labrot, E.S.10
Hu, J.11
Wang, W.12
Xiao, Y.13
Zhang, H.14
Zhang, J.15
Zhang, J.16
-
26
-
-
84877785851
-
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee
-
Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, Simons BW, Ward JM, Robinson BD, Chu GC, Loda M, Thomas G, Borowsky A and Cardiff RD. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res. 2013; 73(9):2718-2736.
-
(2013)
Cancer Res
, vol.73
, Issue.9
, pp. 2718-2736
-
-
Ittmann, M.1
Huang, J.2
Radaelli, E.3
Martin, P.4
Signoretti, S.5
Sullivan, R.6
Simons, B.W.7
Ward, J.M.8
Robinson, B.D.9
Chu, G.C.10
Loda, M.11
Thomas, G.12
Borowsky, A.13
Cardiff, R.D.14
-
27
-
-
10744222860
-
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
-
Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X and Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003; 4(3):209-221.
-
(2003)
Cancer Cell
, vol.4
, Issue.3
, pp. 209-221
-
-
Wang, S.1
Gao, J.2
Lei, Q.3
Rozengurt, N.4
Pritchard, C.5
Jiao, J.6
Thomas, G.V.7
Li, G.8
Roy-Burman, P.9
Nelson, P.S.10
Liu, X.11
Wu, H.12
-
28
-
-
0034520311
-
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo
-
Zhang J, Thomas TZ, Kasper S and Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology. 2000; 141(12):4698-4710.
-
(2000)
Endocrinology
, vol.141
, Issue.12
, pp. 4698-4710
-
-
Zhang, J.1
Thomas, T.Z.2
Kasper, S.3
Matusik, R.J.4
-
29
-
-
84857841703
-
Allosteric antibody inhibition of human hepsin protease
-
Koschubs T, Dengl S, Durr H, Kaluza K, Georges G, Hartl C, Jennewein S, Lanzendorfer M, Auer J, Stern A, Huang KS, Packman K, Gubler U, Kostrewa D, Ries S, Hansen S, et al. Allosteric antibody inhibition of human hepsin protease. The Biochemical journal. 2012; 442(3):483-494.
-
(2012)
The Biochemical journal
, vol.442
, Issue.3
, pp. 483-494
-
-
Koschubs, T.1
Dengl, S.2
Durr, H.3
Kaluza, K.4
Georges, G.5
Hartl, C.6
Jennewein, S.7
Lanzendorfer, M.8
Auer, J.9
Stern, A.10
Huang, K.S.11
Packman, K.12
Gubler, U.13
Kostrewa, D.14
Ries, S.15
Hansen, S.16
-
30
-
-
84863251886
-
An allosteric anti-hepsin antibody derived from a constrained phage display library
-
Ganesan R, Zhang Y, Landgraf KE, Lin SJ, Moran P and Kirchhofer D. An allosteric anti-hepsin antibody derived from a constrained phage display library. Protein engineering, design & selection : PEDS. 2012; 25(3):127-133.
-
(2012)
Protein engineering, design & selection : PEDS
, vol.25
, Issue.3
, pp. 127-133
-
-
Ganesan, R.1
Zhang, Y.2
Landgraf, K.E.3
Lin, S.J.4
Moran, P.5
Kirchhofer, D.6
-
31
-
-
0023850048
-
A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells
-
Leytus SP, Loeb KR, Hagen FS, Kurachi K and Davie EW. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry. 1988; 27(3):1067-1074.
-
(1988)
Biochemistry
, vol.27
, Issue.3
, pp. 1067-1074
-
-
Leytus, S.P.1
Loeb, K.R.2
Hagen, F.S.3
Kurachi, K.4
Davie, E.W.5
-
32
-
-
0032518561
-
Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease
-
Wu Q, Yu D, Post J, Halks-Miller M, Sadler JE and Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. The Journal of clinical investigation. 1998; 101(2):321-326.
-
(1998)
The Journal of clinical investigation
, vol.101
, Issue.2
, pp. 321-326
-
-
Wu, Q.1
Yu, D.2
Post, J.3
Halks-Miller, M.4
Sadler, J.E.5
Morser, J.6
-
33
-
-
0033724609
-
Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability
-
Yu IS, Chen HJ, Lee YS, Huang PH, Lin SR, Tsai TW and Lin SW. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thrombosis and haemostasis. 2000; 84(5):865-870.
-
(2000)
Thrombosis and haemostasis
, vol.84
, Issue.5
, pp. 865-870
-
-
Yu, I.S.1
Chen, H.J.2
Lee, Y.S.3
Huang, P.H.4
Lin, S.R.5
Tsai, T.W.6
Lin, S.W.7
-
34
-
-
34548321253
-
Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss
-
Guipponi M, Tan J, Cannon PZ, Donley L, Crewther P, Clarke M, Wu Q, Shepherd RK and Scott HS. Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss. The American journal of pathology. 2007; 171(2):608-616.
-
(2007)
The American journal of pathology
, vol.171
, Issue.2
, pp. 608-616
-
-
Guipponi, M.1
Tan, J.2
Cannon, P.Z.3
Donley, L.4
Crewther, P.5
Clarke, M.6
Wu, Q.7
Shepherd, R.K.8
Scott, H.S.9
-
35
-
-
84868205856
-
Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice
-
Hsu YC, Huang HP, Yu IS, Su KY, Lin SR, Lin WC, Wu HL, Shi GY, Tao MH, Kao CH, Wu YM, Martin PE, Lin SY, Yang PC and Lin SW. Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice. Hepatology. 2012; 56(5):1913-1923.
-
(2012)
Hepatology
, vol.56
, Issue.5
, pp. 1913-1923
-
-
Hsu, Y.C.1
Huang, H.P.2
Yu, I.S.3
Su, K.Y.4
Lin, S.R.5
Lin, W.C.6
Wu, H.L.7
Shi, G.Y.8
Tao, M.H.9
Kao, C.H.10
Wu, Y.M.11
Martin, P.E.12
Lin, S.Y.13
Yang, P.C.14
Lin, S.W.15
-
36
-
-
63049086099
-
Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides
-
Beliveau F, Desilets A and Leduc R. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. The FEBS journal. 2009; 276(8):2213-2226.
-
(2009)
The FEBS journal
, vol.276
, Issue.8
, pp. 2213-2226
-
-
Beliveau, F.1
Desilets, A.2
Leduc, R.3
-
37
-
-
74049093947
-
Application of the PM6 semiempirical method to modeling proteins enhances docking accuracy of AutoDock
-
Bikadi Z and Hazai E. Application of the PM6 semiempirical method to modeling proteins enhances docking accuracy of AutoDock. Journal of cheminformatics. 2009; 1:15.
-
(2009)
Journal of cheminformatics
, vol.1
, pp. 15
-
-
Bikadi, Z.1
Hazai, E.2
|